Trial intelligence / Profile preview

Erythropoietin in ischemic heart disease

2005-004853-86Phase 2Completed

Sponsor
Policlinico Gemelli
Start
Jan 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised trial in myocardial infarction (MI) and angina pectoris comparing Erythropoietin with Placebo (2 arms). Primary endpoints: Primary endpoint for AMI cohort and Primary endpoint for CSA cohort. Started Jan 2006; status: completed.

02

Drugs

erythropoietin
03

Conditions

myocardial infarction (MI)angina pectoris

Beyond the preview

Go deeper on 2005-004853-86.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004853-86.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call